Patents by Inventor Tomoko Maegawa

Tomoko Maegawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060193925
    Abstract: The present invention relates to a side effect-relieving agent for thiazolidine compounds which comprises a crude drug mixture as an active ingredient comprising Ephedrae Herba, Glycyrrhizae Radix and Gypsum Fibrosum each of which is in a form of ground powders, extracts or mixtures of powders and extracts; and a hypoglycemic effect enhancer for thiazolidine compounds which comprises a crude drug mixture as an active ingredient comprising Ephedrae Herba, Glycyrrhizae Radix and Gypsum Fibrosum each of which is in a form of ground powders, extracts or mixtures of powders and extracts. Using the preparation according to the present invention, body weight gain, which is a side effect of thiazolidine compounds, can be relieved and the hypoglycemic effect of the thiazolidine compounds can be enhanced.
    Type: Application
    Filed: April 26, 2006
    Publication date: August 31, 2006
    Inventors: Yasuo Morimoto, Tomoko Maegawa
  • Publication number: 20040224033
    Abstract: The present invention relates to a side effect-relieving agent for thiazolidine compounds which comprises a crude drug as an active ingredient comprising Ephedrae Herba, Glycyrrhizae Radix and Gypsum Fibrosum each of which is in a form of ground powders, extracts or mixtures of powders and extracts; and a hypoglycemic effect enhancer for thiazolidine compounds which comprises a crude drug as an active ingredient comprising Ephedrae Herba, Glycyrrhizae Radix and Gypsum Fibrosum each of which is in a form of ground powders, extracts or mixtures of powders and extracts. Using the preparation according to the present invention, body weight gain, which is a side effect of thiazolidine compounds, can be relieved and the hypoglycemic effect of the thiazolidine compounds can be enhanced.
    Type: Application
    Filed: February 6, 2004
    Publication date: November 11, 2004
    Applicant: KANEBO, LIMITED
    Inventors: Yasuo Morimoto, Tomoko Maegawa